BYND Investors Have Opportunity to Lead Beyond Meat, Inc. Securities Fraud Lawsuit
prnewswire.com
Want to monitor XCUR?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor XCURexicure, formerly aurasense therapeutics, is developing a new class of immunomodulatory and gene silencing drugs against validated targets. our 3-dimensional, spherical nucleic acid (sna™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. our lead programs address diseases from inflammatory disorders to oncology.